Orca Bio vs Emulate

Side-by-side comparison of AI visibility scores, market position, and capabilities

Emulate leads in AI visibility (74 vs 35)
Orca Bio logo

Orca Bio

EmergingLife Sciences & BioTech

Precision Cell Therapy for Cancer & Autoimmune Disease

Orca Bio is developing high-purity precision cell therapies using proprietary cell sorting technology to improve the safety and outcomes of bone marrow transplantation; raised $270M+; lead programs in AML, MDS, and other blood cancers;

AI VisibilityBeta
Overall Score
D35
Category Rank
#141 of 198
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
36
Perplexity
29
Gemini
37

About

Orca Bio is a Menlo Park, California-based biotechnology company founded in 2016 that is developing next-generation cell therapies for blood cancers and autoimmune diseases through a proprietary high-precision cell sorting and manufacturing platform. The company's core technology enables the production of precisely defined cell therapy products — specifically, highly purified stem cell grafts and engineered immune cell compositions for allogeneic (donor-to-patient) bone marrow transplantation. Unlike conventional bone marrow transplants, which transfer a heterogeneous mixture of cells that can attack the patient's body (graft-versus-host disease, or GVHD), Orca Bio's manufactured grafts are composed of precisely selected cell populations that retain the anti-cancer effect while dramatically reducing the cells responsible for GVHD.

Full profile
Emulate logo

Emulate

LeaderLife Sciences & BioTech

Organ-on-Chip & Drug Development Tools

Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma companies; launched AVA™ high-throughput 96-chip system in 2025 and holds the only FDA ISTAND-accepted DILI Organ-Chip.

AI VisibilityBeta
Overall Score
B74
Category Rank
#8 of 198
AI Consensus
73%
Trend
stable
Per Platform
ChatGPT
78
Perplexity
73
Gemini
77

About

Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the microstructure and function of human organs. Founded in 2013 as a spin-out from the Wyss Institute at Harvard University, Emulate's chips model the liver, intestine, lung, kidney, brain, and other organ systems with a fidelity that animal models and traditional cell culture cannot match. The technology was originally developed to reduce drug development attrition rates caused by poor translation from animal studies to human clinical outcomes.

Full profile

AI Visibility Head-to-Head

35
Overall Score
74
#141
Category Rank
#8
79
AI Consensus
73
stable
Trend
stable
36
ChatGPT
78
29
Perplexity
73
37
Gemini
77
31
Claude
79
35
Grok
68

Key Details

Category
Precision Cell Therapy for Cancer & Autoimmune Disease
Organ-on-Chip & Drug Development Tools
Tier
Emerging
Leader
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.